Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: A critical review of the literature

[1]  Haiqun Lin,et al.  Association of major depression with subtypes of nicotine dependence found among adult daily smokers: a latent class analysis. , 2009, Drug and alcohol dependence.

[2]  J. Denollet,et al.  Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis , 2009, Psychological Medicine.

[3]  I. López-Vílchez,et al.  Serotonergic mechanisms enhance platelet-mediated thrombogenicity , 2009, Thrombosis and Haemostasis.

[4]  J. Jokinen,et al.  HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. , 2009, Journal of affective disorders.

[5]  C. Lavie,et al.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. , 2009, Journal of the American College of Cardiology.

[6]  V. Vaccarino,et al.  Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. , 2009, Archives of general psychiatry.

[7]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[8]  K. Tracey,et al.  The Selective α7 Agonist GTS-21 Attenuates Cytokine Production in Human Whole Blood and Human Monocytes Activated by Ligands for TLR2, TLR3, TLR4, TLR9, and RAGE , 2009, Molecular medicine.

[9]  B. Leonard,et al.  The psychoneuroimmunology of depression , 2009, Human psychopharmacology.

[10]  R. Carney,et al.  Depression and heart rate variability in patients with coronary heart disease , 2009, Cleveland Clinic Journal of Medicine.

[11]  Mary A Whooley,et al.  Depression and Whole Blood Serotonin in Patients With Coronary Heart Disease From the Heart and Soul Study , 2009, Psychosomatic medicine.

[12]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[13]  L. Jonasson,et al.  Inflammation and cortisol response in coronary artery disease , 2009, Annals of medicine.

[14]  A. Johnson,et al.  Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models , 2009, Stress.

[15]  E. Steyerberg,et al.  Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia. , 2008, The Journal of clinical endocrinology and metabolism.

[16]  E. Vittinghoff,et al.  Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. , 2008, JAMA.

[17]  Mary A Whooley,et al.  Depression screening and patient outcomes in cardiovascular care: a systematic review. , 2008, JAMA.

[18]  J. Dimsdale,et al.  The relationship between heart rate variability and inflammatory markers in cardiovascular diseases , 2008, Psychoneuroendocrinology.

[19]  C. Gragnoli,et al.  What do we know about serotonin? , 2008, Journal of cellular physiology.

[20]  J. Spertus,et al.  Acute Coronary Syndrome Patients With Depression Have Low Blood Cell Membrane Omega-3 Fatty Acid Levels , 2008, Psychosomatic medicine.

[21]  C. Villalón,et al.  5-hydroxytryptamine and cardiovascular regulation. , 2008, Trends in pharmacological sciences.

[22]  R. de Caterina,et al.  Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[23]  A. Janssens,et al.  Meta-analyses of genetic studies on major depressive disorder , 2008, Molecular Psychiatry.

[24]  A. Siracusano,et al.  Correlations between personality factors and coronary artery disease: from type A behaviour pattern to type D personality , 2008, Journal of cardiovascular medicine.

[25]  P. de Jonge,et al.  Heterogeneity of patients with coronary artery disease and distress and the need to identify relevant subtypes. , 2008, Archives of general psychiatry.

[26]  L. Manzoli,et al.  Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. , 2008, European heart journal.

[27]  N. Tzanakis,et al.  Adipose DHA inversely associated with depression as measured by the Beck Depression Inventory. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[28]  V. Arango,et al.  Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides , 2008, Molecular Psychiatry.

[29]  D. Grobbee,et al.  Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[30]  S. Reis,et al.  Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. , 2007, Journal of the American College of Cardiology.

[31]  I. Nyklíček,et al.  Depression and anxiety as predictors of heart rate variability after myocardial infarction , 2007, Psychological Medicine.

[32]  P. de Jonge,et al.  Differential Association of Cognitive and Somatic Depressive Symptoms With Heart Rate Variability in Patients With Stable Coronary Heart Disease: Findings From the Heart and Soul Study , 2007, Psychosomatic medicine.

[33]  A. Schene,et al.  Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. , 2007, The American journal of psychiatry.

[34]  H. V. van Hout,et al.  Depression and the risk for cardiovascular diseases: systematic review and meta analysis , 2007, International journal of geriatric psychiatry.

[35]  A. Schene,et al.  Effects of antidepressant treatment following myocardial infarction , 2007, British Journal of Psychiatry.

[36]  J. Mehta,et al.  Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. , 2007, The American journal of cardiology.

[37]  S. Bandinelli,et al.  Hypercortisolemic depression is associated with the metabolic syndrome in late-life , 2007, Psychoneuroendocrinology.

[38]  N. Frasure-smith,et al.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. , 2007, JAMA.

[39]  T. Peters,et al.  Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. , 2006, The American journal of clinical nutrition.

[40]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[41]  S. Chalon.  Omega-3 fatty acids and monoamine neurotransmission. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[42]  R. Carney,et al.  Coronary Heart Disease and Depression: A Review of Recent Mechanistic Research , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[43]  C. Stefanadis,et al.  Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. , 2006, Cytokine & growth factor reviews.

[44]  A. Kafatos,et al.  Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete , 2006, European Journal of Clinical Nutrition.

[45]  P. Calder,et al.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[46]  Florian Holsboer,et al.  Polymorphisms of the Glucocorticoid Receptor Gene and Major Depression , 2006, Biological Psychiatry.

[47]  M. Dubé,et al.  Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin , 2006, Psychosomatic medicine.

[48]  D. Stewart,et al.  Effect of depression on five-year mortality after an acute coronary syndrome. , 2005, The American journal of cardiology.

[49]  R. Carney,et al.  Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. , 2005, Archives of general psychiatry.

[50]  M. Hori,et al.  Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. , 2005, American heart journal.

[51]  A. Sherwood,et al.  Impaired endothelial function in coronary heart disease patients with depressive symptomatology. , 2005, Journal of the American College of Cardiology.

[52]  Junichiro Hayano,et al.  Low heart rate variability and the effect of depression on post-myocardial infarction mortality. , 2005, Archives of internal medicine.

[53]  C. O'connor,et al.  Hypothesis: Antiplatelet Effects of Selective Serotonin Reuptake Inhibitors Cause Clinical Benefits on Cardiovascular Disease and Increase Risks of Bleeding , 2005, Journal of cardiovascular pharmacology and therapeutics.

[54]  W. Browner,et al.  Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. , 2005, Archives of general psychiatry.

[55]  S. Watts.  5-HT in systemic hypertension: foe, friend or fantasy? , 2005, Clinical science.

[56]  M. P. van den Berg,et al.  Depression as an independent determinant of decreased heart rate variability in patients post myocardial infarction. , 2005, Netherlands Heart Journal.

[57]  Karina W Davidson,et al.  The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. , 2005, Journal of the American College of Cardiology.

[58]  Jerry Suls,et al.  Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. , 2005, Psychological bulletin.

[59]  D. J. Veldhuisen,et al.  Sertraline Causes Strong Coronary Vasodilation: Possible Relevance for Cardioprotection by Selective Serotonin Reuptake Inhibitors , 2004, Cardiovascular Drugs and Therapy.

[60]  J. Tijssen,et al.  Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis , 2004, Psychosomatic medicine.

[61]  C. Herrmann-Lingen,et al.  Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis , 2004, Psychosomatic medicine.

[62]  R. von Känel.  Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? , 2004, Acta psychiatrica Scandinavica.

[63]  C. Marmar,et al.  Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study , 2004, Biological Psychiatry.

[64]  F. Wong,et al.  Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome , 2004, Hepatology.

[65]  N. Frasure-smith,et al.  Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes , 2004, Biological Psychiatry.

[66]  A. Sherwood,et al.  Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment , 2004, Psychosomatic medicine.

[67]  A. Schene,et al.  Time after time: biological factors in the course of recurrent depression , 2013 .

[68]  A. Young,et al.  Corticosteroid-serotonin interactions in depression: a review of the human evidence , 2004, Psychopharmacology.

[69]  B. McEwen,et al.  Association of depression with medical illness: does cortisol play a role? , 2004, Biological Psychiatry.

[70]  J. Korf,et al.  Tryptophan as a Link between Psychopathology and Somatic States , 2003, Psychosomatic medicine.

[71]  N. Schneiderman,et al.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.

[72]  R. Carney,et al.  Clinical depression and inflammatory risk markers for coronary heart disease. , 2002, The American journal of cardiology.

[73]  A. Johnson,et al.  Biological mechanisms in the relationship between depression and heart disease , 2002, Neuroscience & Biobehavioral Reviews.

[74]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[75]  R. Carney,et al.  Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. , 2002, Journal of psychosomatic research.

[76]  R. Califf,et al.  Sertraline treatment of major depression in patients with acute MI or unstable angina , 2002, European Neuropsychopharmacology.

[77]  James A. Blumenthal,et al.  Depression, Heart Rate Variability, and Acute Myocardial Infarction , 2001, Circulation.

[78]  A J Camm,et al.  Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials , 2001, Circulation.

[79]  C. Nemeroff,et al.  Are platelets the link between depression and ischemic heart disease? , 2000, American heart journal.

[80]  James A. Blumenthal,et al.  Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months , 2000, Psychosomatic medicine.

[81]  A. Dierich,et al.  Serotonin 2B receptor is required for heart development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[82]  D. Bush,et al.  Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. , 2000, Archives of internal medicine.

[83]  R. Carney,et al.  Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. , 2000, Journal of psychosomatic research.

[84]  P Weber,et al.  Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[85]  B. Druss,et al.  Mental disorders and use of cardiovascular procedures after myocardial infarction. , 2000, JAMA.

[86]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[87]  D. Horrobin,et al.  Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. , 1998, Journal of affective disorders.

[88]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[89]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[90]  R. Fuller.  Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats , 1995, Behavioural Brain Research.

[91]  P. Whelton,et al.  Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. , 1993, Archives of internal medicine.

[92]  D. J. Veldhuisen,et al.  Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors , 2012, Drugs.

[93]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[94]  B. Thombs,et al.  Prevalence of depression in survivors of acute myocardial infarction , 2007, Journal of General Internal Medicine.

[95]  A. Schene,et al.  Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. , 2006, The American journal of psychiatry.

[96]  J. Passchier,et al.  Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. , 2004, Pharmacopsychiatry.

[97]  G. Chrousos,et al.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states , 2002, Molecular Psychiatry.

[98]  F. Holsboer,et al.  Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. , 2001, Journal of affective disorders.

[99]  K. Ressler,et al.  Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.

[100]  S. Paige,et al.  Increases in heart rate variability with successful treatment in patients with major depressive disorder. , 1993, Psychopharmacology bulletin.